期刊文献+

某院羟乙基淀粉临床应用合理性分析 被引量:4

Rationality Analysis of Hydroxyethyl Starch Clinical Application in A Hospital
原文传递
导出
摘要 目的:为临床合理应用羟乙基淀粉(HES)及防范相关不良反应发生提供参考。方法:回顾性分析某院2014年7月住院患者使用HES的情况,考察其用法用量、适应证等情况及用药前后肾功能、凝血功能等监测指标变化,并评价其使用合理性。结果:该院所用HES为HES 200/0.5氯化钠注射液,为第二代HES。347例患者中,295例在用药前监测了肾功能指标,结果正常,21例在用药后监测了肾功能指标,结果正常;同时,326例在用药前后监测了凝血功能指标,结果均正常。该院HES未用于有严重脓毒症、肾功能不全及有凝血功能障碍的患者。结论:使用HES存在肾损害和引起凝血功能障碍的风险,故用药前后应密切监测相关指标,防范不良反应的发生;并且在其临床应用中需严格掌握适应证、用法用量和注意事项。另外,建议改用安全性较高的第三代HES替换第二代HES。 OBJECTIVE: To provide reference for the clinical rational application and preventing the adverse reactions of hy- droxyethyl starch (HES). METHODS: The HES application of inpatients in a hospital in Jul. 2014 were retrospectively analyzed, the usage and dosage, indications, and the changes of renal fimctions and blood coagulation fimction before and after HES treat- ment were detected, and the application rationality was evaluated. RESULTS: The usage of HES in the hospital was hydroxyethyl starch 200/0.5 and Sodium chloride injection, which was the second generation of HES. In the 347 patients, 295 patients had moni- tored the renal functions before the HES treatment, the result was normal; and 21 patients had monitored the renal functions after HES treatment, the result was normal. Meanwhile, 326 patients had monitored the blood coagulation functions before and after HES treatment, the results were normal. HES was not used for the patient of severe sepsis, renal dysfunctions and coagulopathy in this hospital. CONCLUSIONS:The application of lIES can induce renal damage and coagulation disorder, so relevant indicators should be closely monitored before and after treatment to prevent the incidence of adverse reactions; further more, clinicians should strictly handle indications, usage and dosage and precautions during the clinical application; in addition, it is suggested to replace the second generation of HES by the third generation, which is more safer.
出处 《中国药房》 CAS 北大核心 2016年第12期1623-1625,共3页 China Pharmacy
关键词 羟乙基淀粉 不良反应 肾功能损害 凝血功能障碍 用药监测 Hydroxyethyl starch Adverse reaction Renal function damage Coagulation disorder Medication monitoring
  • 相关文献

参考文献9

  • 1中华医学会麻醉学分会.麻醉手术期间液体治疗专家共识:2014[S].2014-07.
  • 2王天龙.羟乙基淀粉电解质注射液的研究进展[J].中华麻醉学杂志,2013,33(12):1417-1422. 被引量:9
  • 3Myburgh JA,Finfer S,Bellomo R,et al.Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive Care[J].N Engl J Med,2012,367(20):1 901.
  • 4Zarychanski R,Abou-Setta AM,Turgeon AF,et al.Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation:a systematic review and meta-analysis[J].JAMA,2013,309(7):678.
  • 5Brunkhorst FM,Engel C,Bloos F,et al.Intensive insulin therapy and pentastarch resuscitation in severe sepsis[J].N Engl J Med,2008,358(2):125.
  • 6Perner A,Haase N,Guttormsen AB,et al.Hydroxyethyl Starch 130/0.42 versus Ringer’s Acetate in Severe Sepsis[J].N Engl J Med,2012,367(2):124.
  • 7FDA.Public Workshop:Risks and Benefits of Hydroxyethyl Starch Solutions[EB/OL].(2012-09-06)[2014-05-04].http://www.fda.gov/Biologics Blood Vaccines/News Events/Workshops Meetings Conferences/ucm313370.html.
  • 8Dellinger RP,Levy MM,Rhodes A,et al.Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock,2012[J].Intensive Care Med,2013,39(2):165.
  • 9国家食品药品监督管理总局.药品不良反应信息通报(第60期)关注含羟乙基淀粉类药品的肾损伤及死亡率增加风险[EB/OL].(2014-02-26)[2014-12].http://www.sfda.gov.cn/WS01/CL0078/97075.html.

二级参考文献67

  • 1Niemi TY , Miyashita R, Yanmkage M. Colloid solutions: a clinical update. J Anesth,2010,24(6) :913-925.
  • 2Westphal M, James MF, Kozek-Langenecker S, et al. Hydroxyethyl sLm,'hs : different products-- different effects. Anesthesiology, 2009, 111(1) :187-202.
  • 3Kiraly LN, Differding JA, Ennmoto TM, et al. Resuscitation with normal saline (NS) vs. lactated ringers (LR) modulates hypercoagulability and leads to increased blood loss in an uncontrolled hemon'hagie shock swine model. J Trauma, 2006,61 (1):57-64.
  • 4Todd SR, Malinoski D, Muller PJ, et al. Lactated Ringer's is superior to normal saline in the resuscitation of uncontrolled hemorrhagic shock. J Trauma, 2007,62(3) :636-639.
  • 5Prough DS, Bidani A. Hyperchloremic metabolic acidosis is a pre- dictable consequence of intraoperative infusion of 0. 9% saline. Anesthesiology, 1999,90(5) : 1247-1249.
  • 6Scheingraber S, Rehm M, Sehmisch C, et al. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology, 1999,90 ( 5 ) : 1265-1270.
  • 7Phillips CR, Vinecore K, Hagg DS, et al. Resuscitation of hae- morrhagic shock with normal saline vs. lactated Ringer's: effects on oxygenation, extravascular lung water and haemodynamics. Crit Care, 2009,13(2) : R30.
  • 8O' Matley CM, Frumento RJ, Hardy MA, et al. A randomized, double-blind comparison of lactated Ringer' s solution and 0.9% NaCI during renal transplantation. Anesth Analg, 2005,100 (5) : 1518-1524.
  • 9Williams EL, Hildebrand KL, McCormick SA, et al. The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg, 1999,88(5) :999-1003.
  • 10Guidet B, Sonl N, Delia Rocca G, et al. A balanced view of bal- anced solutions. Crit Care, 2010,14(5):325.

共引文献8

同被引文献40

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部